Therapeutic vaccines for melanoma: Progress and problems

Trends in Biotechnology

Volumn 14, Issue 9, 1996, Pages 349-355

  Jones, Vicky E ^a   Mitchell, Malcolm S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CANCER VACCINE;

HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MELANOMA; PRIORITY JOURNAL; REVIEW; VACCINATION;

EID: 0030249161     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-7799(96)10045-7     Document Type: Review

References (43)

1. 1 Mitchell, M. S. et al. (1993) Ann. New York Acad. Sci. 690, 153-165
2. 2 Mitchell, M. S. (1993) in Medical Oncology: Basic Principles and Clinical Management of Cancer (2nd edn) (Calabresi, P. and Schein, P. S., eds), pp. 323-344, McGraw-Hill
3. 3 Quan, W. D., Jr and Mitchell, M. S. (1995) in Cancer Treatment (4th edn) (Haskell, C. M., ed.), pp. 57-69, W. B. Saunders
4. 4 Bystryn, J., Ferrone, S. and Livingston, P., eds (1993) Specific Immunotherapy of Cancer with Vaccines. Ann. New York Acad. Sci. 690
5. 5 Old, L. J. (1981) Cancer Res. 41, 361-375
6. 6 Berd, D., Maguire, H. C., Jr and Mastrangelo, M. J. (1993) Ann. New York Acad. Sci. 690, 147-152
7. 7 Berd, D., Sato, T., Lattime, E. C., Maguire, H. C., Jr and Mastrangelo, M. J. (1994) Proc. Am. Assoc. Cancer Res. 35, 667
8. 8 Kobayashi, H. (1979) Cancer Res. 30, 279-299
9. 9 Nabel, G. J. et al. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11307-11311
10. 10 Elliott, G. T., McLeod, R. A., Perez, J. and von Eschen, K. B. (1992) Proc. Am. Assoc. Cancer Res. 33, 332
11. 11 Mitchell, M. S. (1995) Br. Med. Bull. 51, 631-646
12. 12 Morton, D. L. et al. (1993) Ann. New York Acad. Sci. 690, 120-134
13. 13 Hersey, P. (1993) in Biological Approaches to Cancer Treatment: Biomodulation (Mitchell, M. S., ed.), pp. 302-325, McGraw-Hill
14. 14 Bystryn, J. C. (1993) Ann. New York Acad. Sci. 690, 190-203
15. 15 Wallack, M. K. et al. (1995) Cancer 75, 34-42
16. 16 Ferone, S. (1993) Ann. New York Acad. Sci. 690, 214-224
17. 17 Quan, W. D., Jr, Dean, G. E., Stevenson, L., Merritt, J. A. and Mitchell, M. S. (1993) Proc. Am. Assoc. Cancer Res. 34, 476
18. 18 Livingston, P. O. et al. (1994) J. Clin. Oncol. 12, 1036-1044
19. 19 van der Bruggen, P. et al. (1991) Science 254, 1643-1647
20. 20 Celis, E. et al. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2105-2109
21. 21 Coulie, P. G. et al. (1994) J. Exp. Med. 180, 35-42
22. 22 Kawakami, Y. et al. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 3515-3519
23. 23 Cox, A. L. et al. (1994) Science 264, 716-719
24. 24 Sette, A. et al. (1994) J. Immunol. 153, 5586-5592
25. 25 Darrow, T. L., Slingluff, C. L., Jr and Seigler, H. F. (1989) J. Immunol. 142, 3329-3335
26. 26 Berzofsky, J. A. et al. (1991) J. Clin. Invest. 88, 876-884
27. 27 Kan-Mitchell, J. et al. (1993) Cancer Immunol. Immunother. 37, 15-25
28. 28 Huang, X. Q., Mitchell, M. S., Liggett, P. E., Murphree, A. L. and Kan-Mitchell, J. (1994) Cancer Immunol. Immunother. 38, 399-405
29. 29 Aidoo, M. et al. (1995) Lancet 345, 1003-1007
30. 30 Rabinovich, N. R., McInnes, P., Klein, D. L. and Hall, B. F. (1994) Science 265, 1401-1404
31. 31 Allison, J. P., Hurwitz, A. A. and Leach, D. R. (1995) Curr. Opin. Immunol. 7, 682-686
32. 32 Wang, H., Jenkins, R., Kaido, T., Kan-Mitchell, J., Kohn, D. and Mitchell, M. S. (1996) Proc. Am. Assoc. Cancer Res. 37, 490
33. 33 Dranoff, G. et al. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3539-3543
34. 34 Zatloukal, K. et al. (1995) J. Immunol. 154, 3406-3419
35. 35 Restifo, N. et al. (1992) J. Exp. Med. 175, 1423-1431
36. 36 Kwak, L. W. and Longo, D. (1996) in Cancer Chemotherapy and Biotherapy (Chabner, B. and Longo, D., eds), pp. 749-763, Lippincott-Raven
37. 37 Hadden, J. W. (1994) Int. J. Immunopharmacol. 16, 703-710
38. 38 Bernhard, H., Disis, M. L., Heimfeld, S., Hand, S., Gralow, J. R. and Cheever, M. A. (1995) Cancer Res. 55, 1099-1104
39. 39 Mayordomo, J. I. et al. (1995) Nat. Med. 1, 1297-1302
40. 40 Mitchell, M. S., Kan-Mitchell, J., Kempf, R. A., Harel, W., Shau, H. Y. and Lind, S. (1988) Cancer Res. 48, 5883-5893
41. 41 Mitchell, M. S. et al. (1994) J. Clin. Oncol. 12, 402-411
42. 42 Mitchell, M. S. (1989) J. Clin. Oncol. 7, 121-129
43. 43 Staib, L., Harel, W. and Mitchell, M. S. (1993) Cancer Res. 53, 1113-1121